SEC Form D · filed November 2, 2018
KEMPHARM, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Matthew R. Plooster · Celebration, FLDirectorTimothy J. Sangiovanni · Celebration, FLExecSven L. Guenther · Celebration, FLExecDavid S. Tierney · Celebration, FLDirectorGordon K. Johnson · Celebration, FLExecRichard W. Pascoe · Celebration, FLDirectorR. L. Clifton · Celebration, FLExecJoseph B. Saluri · Celebration, FLDirectorTravis C. Mickle · Celebration, FLExec · Director · PromoterSims Lansing · New York, NYDirectorTodd Hixon · Reston, VAExecCormac Sheehan · New York, NYDirectorJonathan Roney · New York, NYExecStuart N. Ballard · London, United KingdomDirectorKatherine Lewis · Las Vegas, NVDirectorStephen Sarsfield · Las Vegas, NVExecScott Johnson · Reston, VAExec · Director · PromoterKenneth D. Cron · New York, NYExecDanny L. Thompson · Coralville, IADirectorAngela P. Ciampa · BOSTON, MADirectorScott B. Garfield · BOSTON, MADirectorVipon B. Ghai · BOSTON, MAExecScott B. Mcfetridge · BOSTON, MAExecBrian R. Albert · BOSTON, MAExec · Director · PromoterPaul A. Fishbin · BOSTON, MADirectorJoshua A. Liebow · BOSTON, MADirectorMateusz A. Szwarc · BOSTON, MAExecAdrienne Lerner · New York, NYExecDanny L. Thompson · Coralville, IADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗